Predictors of Diagnosis of Emerging Polycystic Ovary Syndrome in Adolescent Girls
Keywords:
syndrome of developing polycystic ovaries, methods of diagnosis
Abstract
The emerging polycystic ovary syndrome (PCOS) as the cause of the first signs of menstrual disorders is well known to reproductologists and gynecologists around the world. This term is new, collective, and the pathogenetic aspects of the disease are not fully understood. Its main manifestation is ovarian hyperandrogenism, which is accompanied by a violation of the cycle in combination with structural morphological changes in the ovaries. The article describes new innovative biochemical and hormonal methods for predicting early markers of polycystic ovary syndrome in adolescent girls.
References
1. Aslonova M.Zh., Ikhtiyarova G.A., Khafizova D.B., Mirzoeva M.R. Microbiological and hormonal characteristics of the formation of non-developing pregnancy // Fundamental and practical issues of immunology and infectious diseases. Collection of scientific articles of the participants of the international scientific-practical conference. UFA. - 2018 .-- S. 9-15.
2. Aslonova MJ, Ikhtiyarova GA, Mavlyanova NN. Association of ITGB3 gene polymorphisms with the risk of developing fetal growth restriction syndrome. MOJ Women’s Health. 2021;10(4):97‒100. DOI: 10.15406/mojwh.2021.10.00296
3. Balter RB and others. Infertile marriage: a textbook for students of pediatric and medical-prophylactic faculties. - Samara, 2015.
4. Cakal E., Ozkaya M., Engin-Ustun Y., Ustun Y. Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome. J. Endocrinol. Invest. 2011; 34 (2): 97-100.
5. Deineka N.V., Tselkovich L.S., Ivanova T.V. and others. Psychological rehabilitation of women suffering from infertility // Perinatal medicine: from pregravid preparation to healthy motherhood and a strong family.
6. Diamanti-Kandarakis E., Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 2012; 33 (6): 981-1030.
7. Endocrine system, sports and physical activity: trans. from English / ed. W.J. Kremer and A.D. Rogola. - Olymp. Literature, 2008 .-- 600 p.
8. Goodman NF, Cobin RH, Futterweit W et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 1. EndocrPract 2015; 21 (11): 1291-300.
9. Gulchekhra Ikhtiyarova, Makhliyo Aslonova, Dilnoza Khafizova, Klichova Feruza Karimovna, Ashurova Nigora. Criteria for prediction of complications in pregnant women with antenatal fetal death.2 European Journal of Research P. 101-109 (2019).
10. Gulnoz Sh. Mavlonova., Gulchexra A. Ikhtiyarova., Ikrom I. Аmonov., Zamira Sh.Kurbanova. The microelement status of girls suffering from juvenile uterine bleeding//European Journal of Molecular & Clinical Medicine ISSN 2515-8260 Volume 07, Issue 02, 2020
11. Ikhtiyarova G.A., Iroda Tosheva, Nargiza Nasrullayeva. Causes of fetal loss syndrome at different gestation times //Asian Journal of Research. - 2017. - № 3 (3). - P. 32 - 41.
12. Ikhtiyarova G.A., Matrizaeva G.Zh., Ismatova M.M. "Gynecologyda Kamshiralik ishi" 2018
13. Ikhtiyarova, G. A., Dustova, N. K., Khasanova M. A., Suleymanova G. S., & Davlatov, S. S. (2021). Pathomorphological changes of the placenta in pregnant women infected with coronavirus COVID-19. International Journal of Pharmaceutical Research, 13(1), 1935-1942. doi: 10.31838/ijpr/2021.13.01.283
14. Ikhtiyarova, G. A., Tosheva, I. I., Aslonova, M. J., & Dustova, N. K. (2020). Prenatal rupture of amnion membranes as A risk of development of obstetrics pathologies. European Journal of Molecular and Clinical Medicine, 7(7), 530-535. Retrieved from www.scopus.com
15. Khashchenko E.P., Uvarova E.V. Modern approaches to the diagnosis and management of patients with polycystic ovary syndrome in adolescence // Obstetrics and gynecology. - 2015. - No. 5. - S. 5-9.
16. Kudratova, D. Sh, Ikhtiyarova, G.A., & Davlatov, S.S. (2021). Medical and social problems of the development of congenital malformations during a pandemic. International Journal of Pharmaceutical Research, 13(1), 756-760. doi: 10.31838/ijpr/2021.13.01.130
17. Kurbanova Z.Sh., Ikhtiyarova G.A., Rozikova D.K. - Anovulatory infertility and polycystic ovary syndrome // Tibbiyotdayangi kun 2 (30/2) 2020 pp. 159-165
18. Kurbanova Z.Sh., Ikhtiyarova G.A., Rozikova D.K. - Causes and methods of diagnosing endocrine infertility and the role of vitamin D in its correction // Tibbiyotdayangi kun 2 (30/2) 2020 pp. 34-38
19. Mavlyanova N.N, Iхtiyarova G.I, Tosheva I.I, et al. The State of the Cytokine Status in Pregnant Women with Fetal Growth Retardation.J Med - ClinRes&Rev. 2020; 4(6): 1-4.
20. Nazarenko T.A. Polycystic ovary syndrome: a modern approach to the diagnosis and treatment of infertility. - 2nd ed. - M .: MEDpress-inform, 2008 .-- S. 21-51.
21. Oripova F.Sh, Ikhtiyarova G. A., Kurbanova Z.Sh. Reproductive rehabilitation of women with chronic inflammatory diseases of the genitals.// Journal of biomedicine and practice special issue 2. - 2020. - P. 56 - 59.
22. Rakhmatullaeva M.M., Ikhtiyarova G.A. " Gynecology and hormonal therapy "2019 Shakhnoza F. Bakhodirova, Gulchekhra A. Ikhtiyarova, Aslonova M.J., Salim S. Davlatov. Features of perinatal outcomes in women after supporting reproductive technologies // European Journal of Molecular & Clinical Medicine ISSN 2515-8260 Volume 07, Issue 02, 2020.p-6350
23. Shifrina Yu.O., Drapkina O.M., Ivashkin V.T. Molecular aspects of insulin resistance // Russian medical news. - 2012. - No. 3. - S. 17-25.
24. Takhmina K. Zavkibekova et al/ Differential markers for the diagnosis of recurrent benign ovarian tumors in women of reproductive and premenopausal age// International Journal of Pharmaceutical Research | Jan - Mar 2021 | Vol 13 | Issue 1. https://doi.org/10.31838/ijpr/2021.13.01.432
25. Аслонова М. Ж., Ихтиярова Г. А., Мавлянова Н.Н. ОЦЕНКА ВЫЯВЛЯЕМОСТИ ПОЛИМОРФИЗМА ГЕНА ИНТЕГРИН АЛЬФА-2 (ГЛИКОПРОТЕИН IA/IIA ТРОМБОЦИТОВ PLAII)(ITGA2) У БЕРЕМЕННЫХ С СИНДРОМОМ ОГРАНИЧЕНИЯ РОСТА ПЛОДА //NAZARIY va KLINIK TIBBIYOT. – С. 19.
26. Ихтиярова Г.А., Аслонова М.Ж., Курбанова З.Ш., Калиматова Д.М. Перспективы диагностики эндометриоза с учетом роли генетических факторов в патогенезе заболевания. РМЖ. Мать и дитя. 2021;1:12-16. DOI: 10.32364/2618-8430-2021-4-1-12-16.
27. Ихтиярова Г.А., Курбанова З.Ш., Розикова Д.К. Причины и методы диагностики эндокринного бесплодия и роль витамина Д в его коррекции// Тиббиётда янги кун. - 2020. - №2(30/2). - C. 34 - 38.
28. З.Ш.Курбанова., М.Ж.Аслонова. Микробиологическая и биохимическая характеристика формирования неразвивающейся беременности// Новости дерматовенерологии и репродуктивного здоровья. 2017. № 3-4 (79-80) (2).- С. 16-19
29. Аслонова М. Ж., Ихтиярова Г. А., Мавлянова Н.Н. ОЦЕНКА ВЫЯВЛЯЕМОСТИ ПОЛИМОРФИЗМА ГЕНА ИНТЕГРИН АЛЬФА-2 (ГЛИКОПРОТЕИН IA/IIA ТРОМБОЦИТОВ PLAII)(ITGA2) У БЕРЕМЕННЫХ С СИНДРОМОМ ОГРАНИЧЕНИЯ РОСТА ПЛОДА //NAZARIY va KLINIK TIBBIYOT. – С. 19.
2. Aslonova MJ, Ikhtiyarova GA, Mavlyanova NN. Association of ITGB3 gene polymorphisms with the risk of developing fetal growth restriction syndrome. MOJ Women’s Health. 2021;10(4):97‒100. DOI: 10.15406/mojwh.2021.10.00296
3. Balter RB and others. Infertile marriage: a textbook for students of pediatric and medical-prophylactic faculties. - Samara, 2015.
4. Cakal E., Ozkaya M., Engin-Ustun Y., Ustun Y. Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome. J. Endocrinol. Invest. 2011; 34 (2): 97-100.
5. Deineka N.V., Tselkovich L.S., Ivanova T.V. and others. Psychological rehabilitation of women suffering from infertility // Perinatal medicine: from pregravid preparation to healthy motherhood and a strong family.
6. Diamanti-Kandarakis E., Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 2012; 33 (6): 981-1030.
7. Endocrine system, sports and physical activity: trans. from English / ed. W.J. Kremer and A.D. Rogola. - Olymp. Literature, 2008 .-- 600 p.
8. Goodman NF, Cobin RH, Futterweit W et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 1. EndocrPract 2015; 21 (11): 1291-300.
9. Gulchekhra Ikhtiyarova, Makhliyo Aslonova, Dilnoza Khafizova, Klichova Feruza Karimovna, Ashurova Nigora. Criteria for prediction of complications in pregnant women with antenatal fetal death.2 European Journal of Research P. 101-109 (2019).
10. Gulnoz Sh. Mavlonova., Gulchexra A. Ikhtiyarova., Ikrom I. Аmonov., Zamira Sh.Kurbanova. The microelement status of girls suffering from juvenile uterine bleeding//European Journal of Molecular & Clinical Medicine ISSN 2515-8260 Volume 07, Issue 02, 2020
11. Ikhtiyarova G.A., Iroda Tosheva, Nargiza Nasrullayeva. Causes of fetal loss syndrome at different gestation times //Asian Journal of Research. - 2017. - № 3 (3). - P. 32 - 41.
12. Ikhtiyarova G.A., Matrizaeva G.Zh., Ismatova M.M. "Gynecologyda Kamshiralik ishi" 2018
13. Ikhtiyarova, G. A., Dustova, N. K., Khasanova M. A., Suleymanova G. S., & Davlatov, S. S. (2021). Pathomorphological changes of the placenta in pregnant women infected with coronavirus COVID-19. International Journal of Pharmaceutical Research, 13(1), 1935-1942. doi: 10.31838/ijpr/2021.13.01.283
14. Ikhtiyarova, G. A., Tosheva, I. I., Aslonova, M. J., & Dustova, N. K. (2020). Prenatal rupture of amnion membranes as A risk of development of obstetrics pathologies. European Journal of Molecular and Clinical Medicine, 7(7), 530-535. Retrieved from www.scopus.com
15. Khashchenko E.P., Uvarova E.V. Modern approaches to the diagnosis and management of patients with polycystic ovary syndrome in adolescence // Obstetrics and gynecology. - 2015. - No. 5. - S. 5-9.
16. Kudratova, D. Sh, Ikhtiyarova, G.A., & Davlatov, S.S. (2021). Medical and social problems of the development of congenital malformations during a pandemic. International Journal of Pharmaceutical Research, 13(1), 756-760. doi: 10.31838/ijpr/2021.13.01.130
17. Kurbanova Z.Sh., Ikhtiyarova G.A., Rozikova D.K. - Anovulatory infertility and polycystic ovary syndrome // Tibbiyotdayangi kun 2 (30/2) 2020 pp. 159-165
18. Kurbanova Z.Sh., Ikhtiyarova G.A., Rozikova D.K. - Causes and methods of diagnosing endocrine infertility and the role of vitamin D in its correction // Tibbiyotdayangi kun 2 (30/2) 2020 pp. 34-38
19. Mavlyanova N.N, Iхtiyarova G.I, Tosheva I.I, et al. The State of the Cytokine Status in Pregnant Women with Fetal Growth Retardation.J Med - ClinRes&Rev. 2020; 4(6): 1-4.
20. Nazarenko T.A. Polycystic ovary syndrome: a modern approach to the diagnosis and treatment of infertility. - 2nd ed. - M .: MEDpress-inform, 2008 .-- S. 21-51.
21. Oripova F.Sh, Ikhtiyarova G. A., Kurbanova Z.Sh. Reproductive rehabilitation of women with chronic inflammatory diseases of the genitals.// Journal of biomedicine and practice special issue 2. - 2020. - P. 56 - 59.
22. Rakhmatullaeva M.M., Ikhtiyarova G.A. " Gynecology and hormonal therapy "2019 Shakhnoza F. Bakhodirova, Gulchekhra A. Ikhtiyarova, Aslonova M.J., Salim S. Davlatov. Features of perinatal outcomes in women after supporting reproductive technologies // European Journal of Molecular & Clinical Medicine ISSN 2515-8260 Volume 07, Issue 02, 2020.p-6350
23. Shifrina Yu.O., Drapkina O.M., Ivashkin V.T. Molecular aspects of insulin resistance // Russian medical news. - 2012. - No. 3. - S. 17-25.
24. Takhmina K. Zavkibekova et al/ Differential markers for the diagnosis of recurrent benign ovarian tumors in women of reproductive and premenopausal age// International Journal of Pharmaceutical Research | Jan - Mar 2021 | Vol 13 | Issue 1. https://doi.org/10.31838/ijpr/2021.13.01.432
25. Аслонова М. Ж., Ихтиярова Г. А., Мавлянова Н.Н. ОЦЕНКА ВЫЯВЛЯЕМОСТИ ПОЛИМОРФИЗМА ГЕНА ИНТЕГРИН АЛЬФА-2 (ГЛИКОПРОТЕИН IA/IIA ТРОМБОЦИТОВ PLAII)(ITGA2) У БЕРЕМЕННЫХ С СИНДРОМОМ ОГРАНИЧЕНИЯ РОСТА ПЛОДА //NAZARIY va KLINIK TIBBIYOT. – С. 19.
26. Ихтиярова Г.А., Аслонова М.Ж., Курбанова З.Ш., Калиматова Д.М. Перспективы диагностики эндометриоза с учетом роли генетических факторов в патогенезе заболевания. РМЖ. Мать и дитя. 2021;1:12-16. DOI: 10.32364/2618-8430-2021-4-1-12-16.
27. Ихтиярова Г.А., Курбанова З.Ш., Розикова Д.К. Причины и методы диагностики эндокринного бесплодия и роль витамина Д в его коррекции// Тиббиётда янги кун. - 2020. - №2(30/2). - C. 34 - 38.
28. З.Ш.Курбанова., М.Ж.Аслонова. Микробиологическая и биохимическая характеристика формирования неразвивающейся беременности// Новости дерматовенерологии и репродуктивного здоровья. 2017. № 3-4 (79-80) (2).- С. 16-19
29. Аслонова М. Ж., Ихтиярова Г. А., Мавлянова Н.Н. ОЦЕНКА ВЫЯВЛЯЕМОСТИ ПОЛИМОРФИЗМА ГЕНА ИНТЕГРИН АЛЬФА-2 (ГЛИКОПРОТЕИН IA/IIA ТРОМБОЦИТОВ PLAII)(ITGA2) У БЕРЕМЕННЫХ С СИНДРОМОМ ОГРАНИЧЕНИЯ РОСТА ПЛОДА //NAZARIY va KLINIK TIBBIYOT. – С. 19.
Published
2022-12-12
How to Cite
Shukhratovna1. Z. (2022). Predictors of Diagnosis of Emerging Polycystic Ovary Syndrome in Adolescent Girls. Central Asian Journal of Medical and Natural Science, 3(6), 361-372. https://doi.org/10.17605/cajmns.v3i6.1217
Section
Articles
